Abstract
Informed consent challenges in first-in-human trials to combat serious neurological diseases: Why informed consent processes must account for the ethical salience of unique life circumstances
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
